B. Metzler seel. Sohn & Co’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-59,068
Closed -$3.44M 744
2023
Q2
$3.44M Buy
59,068
+31,600
+115% +$1.9M 0.05% 271
2023
Q1
$1.96M Buy
27,468
+2,248
+9% +$178K 0.03% 309
2022
Q4
$1.78M Hold
25,220
0.03% 325
2022
Q3
$1.53M Buy
25,220
+363
+1% +$24.4K 0.03% 339
2022
Q2
$1.57M Hold
24,857
0.03% 350
2022
Q1
$1.59M Buy
+24,857
New +$1.66M 0.02% 383

Other funds holding NGVT

B. Metzler seel. Sohn & Co's NGVT Position: Q3 2023 in Review

B. Metzler seel. Sohn & Co sold out of Ingevity (NGVT) in Q3 2023, closing a stake of 59,068 shares — an estimated $3.44M sold.

B. Metzler seel. Sohn & Co first reported a position in NGVT in Q1 2022 and held it in 6 quarters. The position peaked at $3.44M in Q2 2023. 258 funds tracked by Wall St. Rank hold NGVT as of Q3 2023.

  • B. Metzler seel. Sohn & Co reported no remaining Ingevity position as of Q3 2023 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 59,068 Ingevity shares in Q3 2023, an estimated $3.44M.
  • B. Metzler seel. Sohn & Co first reported a position in Ingevity in Q1 2022 and held it in 6 quarters.
  • B. Metzler seel. Sohn & Co's Ingevity position peaked at $3.44M in Q2 2023.
  • 258 funds tracked by Wall St. Rank held Ingevity as of Q3 2023.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q3 2023, filed 13 Nov 2023.